GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CEO Buys Highlight: BH, OPK, ARCP, RSE, AKBA

April 01, 2014 | About:
GuruFocus

GuruFocus

335 followers

According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:

Biglari Holdings Inc. (BH): Chairman and CEO, 10% Owner Sardar Biglari, Bought 6,076 Shares

Chairman and CEO, 10% Owner of Biglari Holdings Inc. (BH) Sardar Biglari, bought 6,076 shares on 03/26/2014 at an average price of $483.47. Biglari Holdings Inc. is an Indiana corporation. It is a diversified holding company engaged in a number of diverse business activities. Biglari Holdings Inc. has a market cap of $831.998 million; its shares were traded at around $483.47 with a P/E ratio of 4.50 and P/S ratio of 0.93. Biglari Holdings Inc. had an annual average earnings growth of 7.30% over the past 10 years.

Biglari recently reported its first quarter fiscal 2014 financial results. The company announced pre-tax operating earnings of $2.85 million during the 12 weeks ended Dec. 18, 2013, compared to $7.91 million during the first fiscal quarter of 2013.

Mario Gabelli (Trades, Portfolio) owns 100,594 shares as of 12/31/2013, which accounts for 0.27% of the $18.65 billion portfolio of GAMCO Investors. Chairman and CEO, 10% Owner Sardar Biglari, bought 6,076 shares of BH stock on 03/26/2014 at the average price of 496.66. Sardar Biglari, owns at least 275,739 shares after this. The price of the stock has decreased by 2.66% since.

Opko Health Inc. (OPK): CEO & Chairman, 10% Owner Phillip Frost  Md Et Al Bought 147,900 Shares

CEO & Chairman, 10% Owner of Opko Health Inc. (OPK) Phillip Frost Md Et Al bought 147,900 shares during the past week at an average price of $8.96. Opko Health Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health Inc. has a market cap of $3.7 billion; its shares were traded at around $8.96 with and P/S ratio of 32.00. Opko Health Inc. had an annual average earnings growth of 4.40% over the past 10 years.

Opko recently reported its fourth quarter and full year 2013 financial results. For the fourth quarter of 2013, consolidated revenues increased about 30% to $20.7 million from $16.2 million in the prior year period. For the year ended Dec. 31, 2013, consolidated revenues more than doubled to $96.5 million from $47.0 million in the prior year.

George Soros (Trades, Portfolio) owns 844,600 shares as of 12/31/2013, an increase of 13.37% from the previous quarter. This position accounts for 0.061% of the $11.78 billion portfolio of Soros Fund Management LLC. Mario Gabelli (Trades, Portfolio) owns 15,000 shares as of 12/31/2013, which accounts for 0.0007% of the $18.65 billion portfolio of GAMCO Investors.

Vice Chairman and CTO Jane Hsiao Ph.D. bought 10,000 shares of OPK stock on 01/30/2014 at the average price of $8.14. Jane Hsiao Ph.D. owns at least 36,818,758 shares after this. The price of the stock has increased by 10.07% since.

American Realty Capital Properties Inc. (ARCP): Chairman of the Board of Directors and CEO Nicholas S. Schorsch Bought 50,000 Shares

Chairman of the Board of Directors and CEO of American Realty Capital Properties Inc. (ARCP) Nicholas S. Schorsch bought 50,000 shares on 03/27/2014 at an average price of $13.94. American Realty Capital Properties Inc. owns and acquires single tenant freestanding commercial real estate that is net leased on a medium-term basis primarily to investment grade credit rated and other credit worthy tenants. American Realty Capital Properties Inc. has a market cap of $10.68 billion; its shares were traded at around $13.94 with and P/S ratio of 10.33. The dividend yield of American Realty Capital Properties Inc. stocks is 6.66%.

EVP, Treasurer, Secretary and CFO Brian S. Block bought 20,000 shares of ARCP stock on 03/27/2014 at the average price of $13.8. Brian S. Block owns at least 9,159 shares after this. The price of the stock has increased by 1.01% since.

Rouse Properties Inc. (RSE): President and CEO Andrew Silberfein Bought 15,000 Shares

President and CEO of Rouse Properties Inc. (RSE) Andrew Silberfein bought 15,000 shares on 03/26/2014 at an average price of $16.98. Rouse Properties Inc. is a Delaware corporation organized in August 2011. Rouse Properties Inc. has a market cap of $980.434 million; its shares were traded at around $16.98 with and P/S ratio of 3.42. The dividend yield of Rouse Properties Inc. stocks is 3.06%.

RSE recently reported its fourth quarter 2013 financial results. Core FFO was $23.1 million, or $0.46 per diluted share, as compared to $18.7 million, or $0.38 per diluted share in the prior year period, a 21% increase over the prior year.

COO Benjamin Schall bought 3,061 shares of RSE stock on 03/26/2014 at the average price of $16.35. Benjamin Schall owns at least 162,677 shares after this. The price of the stock has increased by 3.85% since.

Akebia Therapeutics Inc. (AKBA): President and CEO John P. Butler Bought 13,850 Shares

President and CEO of Akebia Therapeutics Inc. (AKBA) John P. Butler bought 13,850 shares on 03/25/2014 at an average price of $20.00. Akebia Therapeutics Inc. has a market cap of $385.361 million; its shares were traded at around $20.00 .

SVP, CFO and Treasurer Jason Amello bought 4,000 shares of AKBA stock on 03/25/2014 at the average price of $17. Jason Amello owns at least 4,000 shares after this. The price of the stock has increased by 17.65% since.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide